TSHA - Taysha Gene Therapies, Inc.

QQQ $ 440.10 $ 1.87 (0.43 %)

DIA $ 390.34 $ 1.99 (0.51 %)

SPY $ 517.23 $ 2.01 (0.39 %)

TLT $ 90.36 $ 0.05 (0.06 %)

GLD $ 213.95 $ 0.32 (0.15 %)

Previous Close

$ 2.48

Open

$ 2.44

Bid

$ 2.36 x 300

Ask

$ 2.37 x 700

Day's Range

$ 2.34 - $ 2.47

52 Week Range

$ 0.50 - $ 3.89

Volume

1,379,655

Average Volume

Market Cap

287.98M

Beta (5Y Monthly)

$ 1.42

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-19-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-28-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-11-2021	03-31-2021	10-Q
13	03-03-2021	12-31-2020	10-K
14	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Taysha Gene Ther...
05/02/2024 17:20:02

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

Taysha Gene Therapies Announces Regenerati...
05/02/2024 12:10:58

RMAT designation follows FDA's review of available safety and efficacy data from the first three patients dosed with the lo...

11 Analysts Assess Taysha Gene Therapies: ...
04/30/2024 16:00:54

Cantor Fitzgerald Reiterates Overweight on...
04/30/2024 14:27:19

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

Cantor Fitzgerald Reiterates Overweight on...
04/19/2024 14:43:06

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:37:11

Cantor Fitzgerald analyst Kristen Kluska reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight and maintains $7 p...

applied-digital-reports-downbeat-results-joins-nurix-therapeutics-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Applied Digital Reports Downbeat Results, ...
04/12/2024 12:04:19

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday.

Needham Reiterates Buy on Taysha Gene Ther...
04/11/2024 10:26:00

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

roblox-tal-education-and-other-big-stocks-moving-higher-on-wednesday

Roblox, TAL Education And Other Big Stocks...
04/10/2024 14:56:11

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

BlackBerry, Nurix Therapeutics, Tesla And ...
04/09/2024 14:43:45

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

Evaluating Taysha Gene Therapies: Insights...
04/09/2024 12:01:28

Piper Sandler Initiates Coverage On Taysha...
04/09/2024 10:47:32

Piper Sandler analyst Christopher Raymond initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Overweight rating...

spinal-delivery-of-tayshas-gene-therapy-shows-promise-in-rare-childhood-neurodegenerative-disease

Spinal Delivery Of Taysha's Gene Therapy S...
03/21/2024 16:36:27

Promising results from a Phase 1 trial led by NIH: scAAV9/JeT-GAN gene therapy shows potential benefits for giant axonal neurop...

Canaccord Genuity Reiterates Buy on Taysha...
03/21/2024 15:37:21

Canaccord Genuity analyst Whitney Ijem reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

Micron To Rally Around 134%? Here Are 10 T...
03/21/2024 13:15:39

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Chardan Capital Maintains Buy on Taysha Ge...
03/21/2024 08:51:16

Chardan Capital analyst Geulah Livshits maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and raises the price target...

why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Lifecore Biomedical Shares Are Trading...
03/20/2024 18:03:46

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
03/20/2024 17:31:24

sportradar-group-posts-upbeat-earnings-joins-kingsoft-cloud-braskem-and-other-big-stocks-moving-higher-on-wednesday

Sportradar Group Posts Upbeat Earnings, Jo...
03/20/2024 15:41:03

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.